Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People whose body mass index (BMI) is 30 or higher, OR whose BMI is 27 or higher and who also have at least one weight-related health condition (such as diabetes or pre-diabetes, high blood pressure, high cholesterol, sleep apnea, fatty liver disease, or heart disease)
- People who can read and speak Hebrew
Who may not be able to join:
- People for whom the medications Wegovy© or Mounjaro© are considered unsafe — for example, those with a personal or family history of a specific type of thyroid cancer (medullary thyroid cancer), a personal history of a condition called Multiple Endocrine Neoplasia type 2 (MEN2), or those who are currently pregnant, breastfeeding, or trying to become pregnant
- People who have previously had weight-loss (bariatric) surgery or a related non-surgical weight-loss procedure
- People who have chronic pancreatitis (long-term inflammation of the pancreas)
- People who have taken weight-loss medications within one month before joining the trial
- People with type 1 diabetes
- People who have had other major surgery on the digestive system before starting the study medication
- People with an ongoing digestive system condition (such as gastroparesis, coeliac disease, or Inflammatory Bowel Disease)
- People with a confirmed diagnosis of small intestinal bacterial overgrowth (SIBO)
- People with active gastritis or gastroenteritis (stomach or gut inflammation/infection)
- People who regularly use medications that speed up digestion or laxatives
- People with a mental illness that is currently not well controlled
- People with significant decline in thinking or memory abilities
- People who drink more than one alcoholic drink per day (for women) or more than two alcoholic drinks per day (for men)
- People who, once enrolled, choose not to start or stop taking Wegovy© or Mounjaro© and miss more than two injections in a row, or who undergo weight-loss surgery or a related procedure during the study period
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +972747288004
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Gastrointestinal symptoms assessment; Defecation texture; Bowel Movement (BM) frequency; Participants gastrointestinal symptoms report
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.